Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

OPTI-SHIELD

K-Number: K924089 · 1993-03-31

Decision Date1993-03-31
Product CodeEFB
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

OPTI-SHIELD is the device name listed in this FDA 510(k) record. The listed applicant is Fuji Optical Systems, Inc.. It received FDA 510(k) clearance on 1993-03-31 under 510(k) number K924089. The device is classified under product code EFB. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OPTI-SHIELD?

OPTI-SHIELD is a medical device that received FDA 510(k) clearance on 1993-03-31. The listed applicant is Fuji Optical Systems, Inc.. The 510(k) number is K924089.

When did OPTI-SHIELD receive FDA 510(k) clearance?

OPTI-SHIELD received FDA 510(k) clearance on 1993-03-31, under 510(k) number K924089.

Who is the listed applicant for OPTI-SHIELD?

The FDA 510(k) record lists Fuji Optical Systems, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for OPTI-SHIELD?

The FDA product code for OPTI-SHIELD is EFB.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: EFB)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑